Celexa and Reyataz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Reyataz (atazanavir sulfate). Common drug interactions include emotional distress among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Reyataz. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Reyataz?

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. eHealthMe is studying from 11,386 Reyataz users. Check the latest studies of Reyataz.



On Jul, 18, 2026

30 people who take Celexa and Reyataz together, and have interactions are studied.

Celexa and Reyataz drug interactions.

What are the common drug interactions of Celexa and Reyataz, by gender? *:

female:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Ankle fracture
  6. Bone density decreased
  7. Chronic kidney disease
  8. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  9. Mobility decreased (ability to move is reduced)
  10. Renal disorder (kidney disease)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Emotional distress
  3. Foot fracture
  4. Respiratory disorder (respiratory disease)
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  6. Anger
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Disease recurrence
  9. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  10. Dizziness

What are the common drug interactions of Celexa and Reyataz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Bone density decreased
  3. Bone loss
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Drug administration error
  6. Emotional distress
  7. Foot fracture
  8. Fracture
  9. Immune reconstitution syndrome (immune recovery syndrome)
  10. Pain

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Chronic kidney disease
  3. Emotional distress
  4. Pain
  5. Bone density decreased
  6. Bone loss
  7. Drug ineffective
  8. Multiple fractures
  9. Osteonecrosis (death of bone)
  10. Diarrhoea

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Osteopenia (a condition where bone mineral density is lower than normal)
  3. Ankle fracture
  4. Bone density decreased
  5. Chronic kidney disease
  6. Mobility decreased (ability to move is reduced)
  7. Asthma
  8. Dehydration (dryness resulting from the removal of water)
  9. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  10. Foot fracture

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Bone density decreased
  3. Bone loss
  4. Chronic kidney disease
  5. Emotional distress
  6. Multiple fractures
  7. Pain
  8. Osteonecrosis (death of bone)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.67%
  2. High Blood Cholesterol: 2 people, 6.67%
  3. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Reyataz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Reyataz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reyataz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reyataz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and atazanavir sulfate (the active ingredients of Celexa and Reyataz, respectively), and Celexa and Reyataz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: